Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Dutasteride in Facial Acne Vulgaris
NCT07421804Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
Randomised trial in acne vulgaris comparing Topical Dutasteride vs Placebo with Topical Dutasteride vs Triple Combination (2 arms). Primary endpoint: Therapeutic efficacy (clinical, microbiological & psychological) at 16 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dutasteride
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07421804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07421804.